Skip to content

Accolade® TMZF® Hip Stem Outcomes Study

Accolade® TMZF® Study A Prospective, Post-market, Non-randomized, Multi-center Evaluation of the Accolade® TMZF® Hip Stem

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00957658
Enrollment
241
Registered
2009-08-12
Start date
2006-03-31
Completion date
2014-05-31
Last updated
2017-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Keywords

Osteoarthritis

Brief summary

The purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.

Detailed description

A prospective, post-market, multi-centered clinical evaluation of the Accolade® TMZF® hip stem device. All patients enrolled will receive the study device. All study patients will undergo a preoperative central Dual energy X-ray absorptiometry (DXA) scan to determine bone mineral density (BMD) values.

Interventions

DEVICEAccolade® TMZF® Hip Stem

Accolade® TMZF® Hip Stem

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patient is a candidate for a primary total hip replacement. 2. Patient has primary diagnosis of osteoarthritis (OA). 3. Male and non-pregnant female patients ages 18 to 90. 4. Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form. 5. Patient willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. 6. Patient capable of undergoing a pre-op central DXA (dual-energy x-ray absorptiometry) scan for a bone mineral density (BMD) reading.

Exclusion criteria

1. Patient has an active infection within the affected hip joint. 2. Patient requires a revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint. 3. Patient who is morbidly obese, Body Mass Index (BMI) \> 40. 4. Patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device. 5. Patient has the following diagnosed systemic diseases: Paget's disease, renal osteodystrophy, lupus erythematosus, rheumatoid arthritis, metabolic bone disease and sickle cell anemia. 6. Patient is immunologically suppressed or receiving chronic steroids more than 30 days. Patients receiving oral or IV steroids within one month of surgery. 7. Patient is a prisoner.

Design outcomes

Primary

MeasureTime frame
Combined Percentage (%) Cases Without Aseptic Loosening, Intraoperative Femoral Fracture or Thigh Pain2 years

Secondary

MeasureTime frameDescription
Revision/Removal Rates2 and 5 yearsThe percentage (%) of hips with revision or removal of any total hip replacement component (acetabular cup, femoral stem or femoral head) is reported at the 2 and 5 year postoperative intervals.
Change in Harris Hip Score (HHS)Preoperative, 2 and 5 yearsThe change in HHS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent, 80-89 = good, 70-79 = fair, 0-69 = poor.
Change in SF-12 ScorePreoperative, 2 and 5 yearsThe change in SF-12 is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.
Change in Lower Extremity Activity Scale (LEAS) ScorePreoperative, 2 and 5 yearsThe change in LEAS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. The mean preoperative, 2 and 5 year scores are reported to assess improvement.
Percentage (%) of Hip Stems With Aseptic Loosening5 yearsAseptic loosening is defined as a continuous radiolucency that surrounds the entire femoral stem porous coating-bone interface and that measures greater than 2 mm in thickness, and 5 mm or more of stem subsidence. Continuous radiolucency must be present in Zones 1, 2, 6 and 7 of the AP radiographic view and/or present in Zones 8, 9, 13 and 14 of the M/L radiographic view.
PEQ (Patient Evaluation Questionnaire) Percent Achievement6 months, 1 year, 2 yearsThe PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement. EXPECTATIONS KEY: Participate in recreational activities (dancing,traveling,gardening) Exercise or participate in sports Independently perform household chores/daily routine Easily change position,sit to stand/stand to sit Remove need for cane crutch or walker Use stairs normally step by step Ability to sleep through night Maintain social activites,caring for someone,playing with children Use public transportation or drive Maintain psychological well-being Maintain sexual activity Maintain employment
Acetabular Insert Wear5 yearsThe linear wear rate of the polyethylene acetabular insert is measured radiographically and reported at 5 years.
Wrist DXA Scan Analysis5 yearsDXA is a bone densitometry scan that measures bone mineral density and assigns a T-score. This score shows the amount of bone a patient has compared with a young adult of the same gender with peak bone mass. A score above -1 is considered normal. A score between -1 and -2.5 is classified as osteopenia (low bone mass). A score below -2.5 is defined as osteoporosis.
PEQ (Patient Expectation Questionnaire) Overall Satisfaction6 months, 1 year and 2 yearsThe PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement. EXPECTATIONS KEY: Participate in recreational activities (dancing,traveling,gardening) Exercise or participate in sports Independently perform household chores/daily routine Easily change position,sit to stand/stand to sit Remove need for cane crutch or walker Use stairs normally step by step Ability to sleep through night Maintain social activites,caring for someone,playing with children Use public transportation or drive Maintain psychological well-being Maintain sexual activity Maintain employment

Countries

United States

Participant flow

Pre-assignment details

241 participants/249 hips - 7 censored participants/7 hips = 234 participants/242 hips

Participants by arm

ArmCount
Accolade® TMZF® Hip Stem
Accolade® TMZF® Hip Stem Study Device
234
Total234

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath1
Overall StudyIncomplete 2 yr data28
Overall StudyLost to Follow-up4
Overall StudyProtocol Violation5
Overall StudyRevision1
Overall StudySite termination10
Overall Studysurgery cancelled2
Overall Studyunwilling/unable to return2
Overall StudyWithdrawal by Subject12

Baseline characteristics

CharacteristicAccolade® TMZF® Hip Stem
Age, Continuous68.94 years
STANDARD_DEVIATION 9.77
Region of Enrollment
United States
234 participants
Sex/Gender, Customized
Female
149 participants
Sex/Gender, Customized
Male
80 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
54 / 234
serious
Total, serious adverse events
65 / 234

Outcome results

Primary

Combined Percentage (%) Cases Without Aseptic Loosening, Intraoperative Femoral Fracture or Thigh Pain

Time frame: 2 years

ArmMeasureValue (NUMBER)
Accolade® TMZF® Hip StemCombined Percentage (%) Cases Without Aseptic Loosening, Intraoperative Femoral Fracture or Thigh Pain98.85 percentage of hips
Comparison: Literature control = 96% with no aseptic loosening, intraop femoral fracture or thigh pain at 2 yearsp-value: <0.0001Asymptotic WALD test
Secondary

Acetabular Insert Wear

The linear wear rate of the polyethylene acetabular insert is measured radiographically and reported at 5 years.

Time frame: 5 years

Population: Participants with available data: 97 hips were evaluated for wear rate at 5 years.

ArmMeasureValue (MEAN)Dispersion
Accolade® TMZF® Hip StemAcetabular Insert Wear0.0342 millimeters per yearStandard Deviation 0.0336
Comparison: Compare to historical control (n=94 hips): mean wear 5 years = 0.134 (0.078)p-value: <0.0001Wilcoxon (Mann-Whitney)
Secondary

Change in Harris Hip Score (HHS)

The change in HHS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent, 80-89 = good, 70-79 = fair, 0-69 = poor.

Time frame: Preoperative, 2 and 5 years

Population: Participants with available data: A total of 195 hips had a preoperative score, 174 had a 2 year score, and 117 had a 5 year score.

ArmMeasureGroupValue (MEAN)Dispersion
Accolade® TMZF® Hip StemChange in Harris Hip Score (HHS)Mean HHS score Preoperative (n=195)50.1 units on a scaleStandard Deviation 11.99
Accolade® TMZF® Hip StemChange in Harris Hip Score (HHS)Mean HHS score 2 years (n=174)89.4 units on a scaleStandard Deviation 12.67
Accolade® TMZF® Hip StemChange in Harris Hip Score (HHS)Mean HHS score 5 years (N=117)92.2 units on a scaleStandard Deviation 12.61
Comparison: Improvement from preop to 2 year and preop to 5 yearp-value: <0.0001Sign test
Secondary

Change in Lower Extremity Activity Scale (LEAS) Score

The change in LEAS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. The mean preoperative, 2 and 5 year scores are reported to assess improvement.

Time frame: Preoperative, 2 and 5 years

Population: Participants with available data: A total of 231 hips had a preoperative score, 181 had a 2 year, and 129 had a 5 year score.

ArmMeasureGroupValue (MEAN)Dispersion
Accolade® TMZF® Hip StemChange in Lower Extremity Activity Scale (LEAS) ScoreMean LEAS Preoperative (n=231)8.4 units on a scaleStandard Deviation 3.32
Accolade® TMZF® Hip StemChange in Lower Extremity Activity Scale (LEAS) ScoreMean LEAS 2 year (N=181)10.4 units on a scaleStandard Deviation 3.18
Accolade® TMZF® Hip StemChange in Lower Extremity Activity Scale (LEAS) ScoreMean LEAS 5 year (N=129)10.2 units on a scaleStandard Deviation 3.34
Comparison: Compare LEAS score preop to 2 years and preop to 5 yearsp-value: <0.0001Sign test
Secondary

Change in SF-12 Score

The change in SF-12 is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame: Preoperative, 2 and 5 years

Population: Participants with available data: A total of 217 hips had preoperative scores, 175 had 2 year and 121 had 5 year scores.

ArmMeasureGroupValue (MEAN)Dispersion
Accolade® TMZF® Hip StemChange in SF-12 Scoremean SF12 Mental Preoperative (N=217)49.1 units on a scaleStandard Deviation 11.99
Accolade® TMZF® Hip StemChange in SF-12 ScoreMean SF12 Physical 2 years (N=175)45.6 units on a scaleStandard Deviation 11.17
Accolade® TMZF® Hip StemChange in SF-12 ScoreMean SF12 Mental 2 years (N=175)54.2 units on a scaleStandard Deviation 8.41
Accolade® TMZF® Hip StemChange in SF-12 ScoreMean SF-12 Physical 5 years (N=121)44.8 units on a scaleStandard Deviation 10.62
Accolade® TMZF® Hip StemChange in SF-12 ScoreMean SF-12 Mental 5 years (N=121)53.4 units on a scaleStandard Deviation 9.45
Accolade® TMZF® Hip StemChange in SF-12 ScoreMean SF12 Physical Preoperative (N=217)32.3 units on a scaleStandard Deviation 8.3
Comparison: Compare Pre-op SF-12 Physical Score preop to 2 year and preop to 5 yearp-value: <0.0001t-test, 2 sided
Comparison: Change in SF-12 Mental Score preop to 2 yearsp-value: <0.0001Sign test
Comparison: Compare SF-12 Mental Score preop to 5 yearsp-value: 0.0004t-test, 2 sided
Secondary

PEQ (Patient Evaluation Questionnaire) Percent Achievement

The PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement. EXPECTATIONS KEY: Participate in recreational activities (dancing,traveling,gardening) Exercise or participate in sports Independently perform household chores/daily routine Easily change position,sit to stand/stand to sit Remove need for cane crutch or walker Use stairs normally step by step Ability to sleep through night Maintain social activites,caring for someone,playing with children Use public transportation or drive Maintain psychological well-being Maintain sexual activity Maintain employment

Time frame: 6 months, 1 year, 2 years

Population: Participants with available data: A total of 206 hips had 6 month data; a total of 203 hips had 1 year data; a total of 178 hips had 2 year data. Participants select 3 expectations and assess percent achievement (100%,75%,50%,25%,or 0%) at 6 mos, 1 yr and 2 yrs.

ArmMeasureGroupValue (NUMBER)
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 100% 1 yr (n=97)55.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 100% 2 yr (n=83)47.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 75% 6 mo (n=101)33.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 75% 2 yr (n=83)28.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 50% 6 mo (n=101)9.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 50% 1 yr (n=97)8.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 25% 6 mo (n=101)11.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 25% 1 yr (n=97)3.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 25% 2 yr (n=83)8.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 0% 6 mo (n=101)2.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 100% 6 mo (n=81)43.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 0% 1 yr (n=97)4.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 0% 2 yr (n=83)3.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 100% 1 yr (n=82)51.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 100% 2 yr (n=74)44.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 75% 1 yr (n=82)29.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 75% 2 yr (n=74)32.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 50% 6 mo (n=81)9.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 50% 2 yr (n=74)5.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 50% 1 yr (n=82)9.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 25% 6 mo (n=81)4.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 25% 1 yr (n=82)8.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 25% 2 yr (n=74)13.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 0% 6 mo (n=81)4.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 0% 2 yr (n=74)4.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 100% 1 yr (n=72)65.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 100% 2 yr (n=65)58.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 75% 6 mos (n=74)14.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 25% 2 yr (n=65)6.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 0% 1 yr (n=72)2.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 0% 2 yr (n=65)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 100% 6 mo (n=63)58.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 100% 1 yr (n=61)60.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 100% 2 yr (n=49)57.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 75% 6 mo (n=63)28.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 75% 1 yr (n=61)31.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 75% 2 yr (n=49)26.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 50% 6 mo (n=63)6.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 50% 1 yr (n=61)8.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 50% 2 yr (n=49)14.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 25% 6 mo (n=63)6.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 25% 2 yr (n=49)2.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 0% 6 mo (n=63)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 0% 2 yr (n=49)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 100% 6 mo (n=58)79.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 100% 1 yr (n=54)79.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 100% 2 yr (n=53)77.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 75% 6 mo (n=58)12.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 50% 6 mo (n=58)1.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 25% 1 yr (n=54)5.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 0% 1 yr (n=54)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 0% 2 yr (n=53)1.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 100% 6 mo (n=56)51.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 75% 6 mo (n=56)25 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 75% 1 yr (n=59)6.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 75% 2 yr (n=47)8.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 50% 1 yr (n=59)18.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 50% 2 yr (n=47)19.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 25% 6 mo (n=56)8.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 25% 2 yr (n=47)10.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 0% 6 mo (n=56)7.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 0% 1 yr (n=59)3.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 0% 2 yr (n=47)6.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 100% 6 mo (n=55)43.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 100% 1 yr (n=53)39.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 100% 2 yr (n=51)51.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 75% 1 yr (n=53)28.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 75% 2 yr (n=51)17.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 50% 6 mo (n=55)18.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 25% 6 mo (n=55)7.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 25% 1 yr (n=53)15.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 25% 2 yr (n=51)7.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 0% 6 mo (n=55)10.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 0% 1 yr (n=53)11.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 0% 2 yr (n=51)5.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 100% 6 mo (n=47)61.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 100% 1 yr (n=44)65.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 100% 2 yr (n=40)62.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 75% 6 mo (n=47)19.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 75% 1 yr (n=44)18.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 75% 2 yr (n=40)17.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 50% 6 mo (n=47)12.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 50% 1 yr (n=44)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 25% 6 mo (n=47)4.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 25% 1 yr (n=44)9.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 0% 6 mo (n=47)2.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 0% 1 yr (n=44)6.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 0% 2 yr (n=40)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 100% 2 yr (n=27)77.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 75% 1 yr (n=32)6.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 50% 6 mo (n=30)3.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 25% 1 yr (n=32)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 50% 1 yr (n=32)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 50% 2 yr (n=27)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 25% 6 mo (n=30)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 0% 1 yr (n=32)3.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 100% 6 mo (n=22)54.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 100% 1 yr (n=24)58.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 100% 2 yr (n=17)47.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 75% 2 yr (n=17)35.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 50% 6 mo (n=22)9.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 50% 2 yr (n=17)11.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 25% 6 mo (n=22)4.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 25% 1 yr (n=24)8.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 0% 6 mo (n=22)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 0% 2 yr (n=17)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 100% 6 mo (n=15)26.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 100% 1 yr (n=14)57.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 75% 2 yr (n=14)14.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 50% 6 mo (n=15)20.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 50% 1 yr (n=14)14.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 100% 6 mo (n=101)42.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 75% 1 yr (n=97)28.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementRecreation 50% 2 yr (n=83)12.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 75% 6 mo (n=55)20.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 50% 1 yr (n=53)5.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSleep 50% 2 yr (n=51)17.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 50% 2 yr (n=40)15.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementMaintain activities 25% 2 yr (n=40)5.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 100% 6 mo (n=30)86.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 100% 1 yr (n=32)90.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 75% 6 mo (n=30)10.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 75% 2 yr (n=27)14.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 25% 2 yr (n=27)3.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 0% 6 mo (n=30)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementTransportation 0% 2 yr (n=27)3.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 75% 6 mo (n=22)31.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 75% 1 yr (n=24)33.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 50% 1 yr (n=24)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 25% 2 yr (n=17)5.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementWell-being 0% 1 yr (n=24)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 100% 2 yr (n=14)35.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 75% 6 mo (n=15)33.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 75% 1 yr (n=14)7.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 50% 2 yr (n=14)14.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 25% 6 mo (n=15)20.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 25% 1 yr (n=14)14.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 25% 2 yr (n=14)28.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 0% 6 mo (n=15)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 0% 1 yr (n=14)7.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementSexual activity 0% 2 yr (n=14)7.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 100% 6 mo (n=12)83.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 100% 1 yr (n=12)75.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 100% 2 yr (n=9)88.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 75% 6 mo (n=12)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 75% 1 yr (n=12)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 75% 2 yr (n=9)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 50% 6 mo (n=12)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 50% 1 yr (n=12)8.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 50% 2 yr (n=9)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 25% 6 mo (n=12)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 25% 1 yr (n=12)8.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 25% 2 yr (n=9)0.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 0% 6 mo (n=12)16.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 0% 1 yr (n=12)8.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementEmployment 0% 2 yr (n=9)11.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 75% 6 mo (n=81)37.0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementExercise/sports 0% 1 yr (n=82)1.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 100% 6 mo (n=74)71.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 75% 1 yr (n=72)19.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 75% 2 yr (n=65)27.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 50% 6 mo (n=74)6.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 50% 1 yr (n=72)5.6 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 50% 2 yr (n=65)7.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 25% 6 mo (n=74)6.8 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 25% 1 yr (n=72)6.9 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChores 0% 6 mo (n=74)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 25% 1 yr (n=61)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementChange position 0% 1 yr (n=61)0 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 75% 1 yr (n=54)7.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 75% 2 yr (n=53)7.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 50% 1 yr (n=54)7.4 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 50% 2 yr (n=53)7.5 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 25% 6 mo (n=58)5.2 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 25% 1 yr (n=53)5.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementNo cane/crutch/walker 0% 6 mo (n=58)1.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 100% 1 yr (n=59)62.7 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 100% 2 yr (n=47)55.3 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 50% 6 mo (n=56)7.1 percentage of participants
Accolade® TMZF® Hip StemPEQ (Patient Evaluation Questionnaire) Percent AchievementStairs normally 25% 1 yr (n=59)8.5 percentage of participants
Secondary

PEQ (Patient Expectation Questionnaire) Overall Satisfaction

The PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement. EXPECTATIONS KEY: Participate in recreational activities (dancing,traveling,gardening) Exercise or participate in sports Independently perform household chores/daily routine Easily change position,sit to stand/stand to sit Remove need for cane crutch or walker Use stairs normally step by step Ability to sleep through night Maintain social activites,caring for someone,playing with children Use public transportation or drive Maintain psychological well-being Maintain sexual activity Maintain employment

Time frame: 6 months, 1 year and 2 years

Population: Participants with available data: A total of 206 hips had 6 month data; a total of 203 hips had 1 year data; a total of 178 hips had 2 year data. Percentage of participants who were satisfied with the result is reported for each expectation at these intervals.

ArmMeasureGroupValue (NUMBER)
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionRecreation 6 mo (n=97)84.5 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionRecreation 1 yr (n=95)88.4 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionExercise/sports 6 mo (n=79)89.9 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionExercise/sports 2 yr (n=67)91 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChores 6 mo (n=71)91.5 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChores 1 yr (n=65)86.2 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChange position 1 yr (n=58)87.9 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionStairs normally 1 yr (n=58)86.2 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionStairs normally 2 yr (n=45)91.1 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionMaintain activities 6 mo (n=44)90.9 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionMaintain activities 1 yr (n=41)87.8 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionMaintain activities 2 yr (n=38)94.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionTransportation 6 mo (n=27)96.3 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionTransportation 1 yr (n=29)96.6 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionTransportation 2 yr (n=24)95.8 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionWell-being 1 yr (n=20)95 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionWell-being 2 yr (n=15)86.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSexual activity 6 mo (n=15)80 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSexual activity 1 yr (n=13)84.6 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSexual activity 2 yr (n=12)66.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionEmployment 6 mo (n=12)83.3 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionEmployment 2 yr (n=8)87.5 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionRecreation 2 yr (n=76)85.5 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionExercise/sports 1 yr (n=79)89.9 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChores 2 yr (n=58)96.6 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChange position 6 mo (n=57)87.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionChange position 2 yr (n=43)90.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionNo cane/crutch/walker 6 mo (n=57)94.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionNo cane/crutch/walker 1 yr (n=53)94.3 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionNo cane/crutch/walker 2 yr (n=49)93.9 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionStairs normally 6 mo (n=52)80.8 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSleep 6 mo (n=52)71.2 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSleep 1 yr (n=49)77.6 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionSleep 2 yr (n=51)84.3 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionWell-being 6 mo (n=21)85.7 percentage of particpants
Accolade® TMZF® Hip StemPEQ (Patient Expectation Questionnaire) Overall SatisfactionEmployment 1 yr (n=11)81.8 percentage of particpants
Secondary

Percentage (%) of Hip Stems With Aseptic Loosening

Aseptic loosening is defined as a continuous radiolucency that surrounds the entire femoral stem porous coating-bone interface and that measures greater than 2 mm in thickness, and 5 mm or more of stem subsidence. Continuous radiolucency must be present in Zones 1, 2, 6 and 7 of the AP radiographic view and/or present in Zones 8, 9, 13 and 14 of the M/L radiographic view.

Time frame: 5 years

Population: Participants with available data: 111 hips in 106 participants had a radiographic evaluation at 5 years.

ArmMeasureValue (NUMBER)
Accolade® TMZF® Hip StemPercentage (%) of Hip Stems With Aseptic Loosening0 percentage of hips
Secondary

Revision/Removal Rates

The percentage (%) of hips with revision or removal of any total hip replacement component (acetabular cup, femoral stem or femoral head) is reported at the 2 and 5 year postoperative intervals.

Time frame: 2 and 5 years

Population: Participants with available data: The revision/removal rate of any total hip replacement component at 2 years is reported for 182 hips/176 participants. The revision/removal rate of any component at 5 years is reported for 141 hips/136 participants.

ArmMeasureGroupValue (NUMBER)
Accolade® TMZF® Hip StemRevision/Removal RatesRevision/removal rate % at 2 years1.65 percentage of hips/any component revised
Accolade® TMZF® Hip StemRevision/Removal RatesRevision/removal rate % at 5 years2.84 percentage of hips/any component revised
Secondary

Wrist DXA Scan Analysis

DXA is a bone densitometry scan that measures bone mineral density and assigns a T-score. This score shows the amount of bone a patient has compared with a young adult of the same gender with peak bone mass. A score above -1 is considered normal. A score between -1 and -2.5 is classified as osteopenia (low bone mass). A score below -2.5 is defined as osteoporosis.

Time frame: 5 years

Population: Participants with available data: 107 hips had DXA scan T-scores at 5 years.

ArmMeasureValue (MEAN)Dispersion
Accolade® TMZF® Hip StemWrist DXA Scan Analysis-0.4 T-scoreStandard Deviation 1.05
Comparison: Compare Wrist DXA T-score preop to 5 yearsp-value: 0.0002Sign test

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026